AW
MLYS icon

Avion Wealth’s Mineralys Therapeutics MLYS Stock Holding History

Avion Wealth’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
21
– – ﹤0.01% 1616
2026
Q1 		$0 Hold
21
– – ﹤0.01% 1464
2025
Q4 		$0 Sell
21
-57
-73% -$2.29K ﹤0.01% 1455
2025
Q3 		$2K Hold
78
– – ﹤0.01% 878
2025
Q2 		$1K Hold
78
– – ﹤0.01% 1013
2025
Q1 		$0 Buy
+78
New +$897 ﹤0.01% 1234
2024
Q4 		– Sell
-78
Closed – – 1178
2024
Q3 		$0 Hold
78
– – ﹤0.01% 1213
2024
Q2 		$0 Hold
78
– – ﹤0.01% 1136
2024
Q1 		$2K Hold
78
– – ﹤0.01% 720
2023
Q4 		$1K Buy
+78
New +$612 ﹤0.01% 874

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Avion Wealth's MLYS Position: Q2 2026 in Review

Avion Wealth held its Mineralys Therapeutics (MLYS) position steady in Q2 2026 at 21 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Avion Wealth first reported a position in MLYS in Q4 2023 and has held it in 10 quarters since. The position peaked at $2K in Q3 2025. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Avion Wealth held 21 shares of Mineralys Therapeutics worth $0 as of Q2 2026.
  • Avion Wealth left its Mineralys Therapeutics share count unchanged in Q2 2026.
  • Mineralys Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1616 holding.
  • Avion Wealth first reported a position in Mineralys Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Avion Wealth's Mineralys Therapeutics position peaked at $2K in Q3 2025.
  • 226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.